Nucleophosmin (NPM1)

The protein contains 294 amino acids for an estimated molecular weight of 32575 Da.

 

Involved in diverse cellular processes such as ribosome biogenesis, centrosome duplication, protein chaperoning, histone assembly, cell proliferation, and regulation of tumor suppressors p53/TP53 and ARF. Binds ribosome presumably to drive ribosome nuclear export. Associated with nucleolar ribonucleoprotein structures and bind single-stranded nucleic acids. Acts as a chaperonin for the core histones H3, H2B and H4. Stimulates APEX1 endonuclease activity on apurinic/apyrimidinic (AP) double-stranded DNA but inhibits APEX1 endonuclease activity on AP single-stranded RNA. May exert a control of APEX1 endonuclease activity within nucleoli devoted to repair AP on rDNA and the removal of oxidized rRNA molecules. In concert with BRCA2, regulates centrosome duplication. Regulates centriole duplication: phosphorylation by PLK2 is able to trigger centriole replication. Negatively regulates the activation of EIF2AK2/PKR and suppresses apoptosis through inhibition of EIF2AK2/PKR autophosphorylation. Antagonizes the inhibitory effect of ATF5 on cell proliferation and relieves ATF5-induced G2/M blockade (PubMed:22528486). In complex with MYC enhances the transcription of MYC target genes (PubMed:25956029). (updated: Jan. 31, 2018)

Protein identification was indicated in the following studies:

  1. Goodman and co-workers. (2013) The proteomics and interactomics of human erythrocytes. Exp Biol Med (Maywood) 238(5), 509-518.
  2. Hegedűs and co-workers. (2015) Inconsistencies in the red blood cell membrane proteome analysis: generation of a database for research and diagnostic applications. Database (Oxford) 1-8.
  3. Wilson and co-workers. (2016) Comparison of the Proteome of Adult and Cord Erythroid Cells, and Changes in the Proteome Following Reticulocyte Maturation. Mol Cell Proteomics. 15(6), 1938-1946.

Methods

The following articles were analysed to gather the proteome content of erythrocytes.

The gene or protein list provided in the studies were processed using the ID mapping API of Uniprot in September 2018. The number of proteins identified and mapped without ambiguity in these studies is indicated below.
Only Swiss-Prot entries (reviewed) were considered for protein evidence assignation.

PublicationIdentification 1Uniprot mapping 2Not mapped /
Obsolete
TrEMBLSwiss-Prot
Goodman (2013)2289 (gene list)227853205992269
Lange (2014)123412347281224
Hegedus (2015)2638262202352387
Wilson (2016)165815281702911068
d'Alessandro (2017)18261817201815
Bryk (2017)20902060101081942
Chu (2018)18531804553621387

1 as available in the article and/or in supplementary material
2 uniprot mapping returns all protein isoforms as one entry

The compilation of older studies can be retrieved from the Red Blood Cell Collection database.

The data and differentiation stages presented below come from the proteomic study and analysis performed by our partners of the GReX consortium, more details are available in their published work.

No sequence conservation computed yet.

Interpro domains
Total structural coverage: 63%
Model score: 24

(right-click above to access to more options from the contextual menu)

Biological Process

Cell aging GO Logo
Cell volume homeostasis GO Logo
Cellular response to UV GO Logo
CENP-A containing nucleosome assembly GO Logo
Centrosome cycle GO Logo
Chromatin remodeling GO Logo
DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest GO Logo
DNA repair GO Logo
Intracellular protein transport GO Logo
Negative regulation of apoptotic process GO Logo
Negative regulation of cell population proliferation GO Logo
Negative regulation of centrosome duplication GO Logo
Negative regulation of mRNA splicing, via spliceosome GO Logo
Negative regulation of protein kinase activity by regulation of protein phosphorylation GO Logo
Nucleocytoplasmic transport GO Logo
Nucleosome assembly GO Logo
Positive regulation of cell cycle G2/M phase transition GO Logo
Positive regulation of cell population proliferation GO Logo
Positive regulation of centrosome duplication GO Logo
Positive regulation of NF-kappaB transcription factor activity GO Logo
Positive regulation of protein kinase activity GO Logo
Positive regulation of protein localization to nucleolus GO Logo
Positive regulation of protein ubiquitination GO Logo
Positive regulation of transcription by RNA polymerase II GO Logo
Positive regulation of transcription, DNA-templated GO Logo
Positive regulation of translation GO Logo
Protein complex oligomerization GO Logo
Protein localization GO Logo
Protein stabilization GO Logo
Regulation of cell growth GO Logo
Regulation of centriole replication GO Logo
Regulation of centrosome duplication GO Logo
Regulation of DNA damage response, signal transduction by p53 class mediator GO Logo
Regulation of eIF2 alpha phosphorylation by dsRNA GO Logo
Regulation of endodeoxyribonuclease activity GO Logo
Regulation of endoribonuclease activity GO Logo
Regulation of mRNA stability involved in cellular response to UV GO Logo
Regulation of transcription by RNA polymerase II GO Logo
Response to stress GO Logo
Ribosomal large subunit biogenesis GO Logo
Ribosomal large subunit export from nucleus GO Logo
Ribosomal small subunit biogenesis GO Logo
Ribosomal small subunit export from nucleus GO Logo
Ribosome assembly GO Logo
RRNA export from nucleus GO Logo
Signal transduction GO Logo
Viral process GO Logo

The reference OMIM entry for this protein is 164040

Nucleophosmin/nucleoplasmin family, member 1; npm1
Nucleophosmin; npm
Nucleolar phosphoprotein b23
Numatrin npm1/alk fusion gene, included

DESCRIPTION

NPM1 is a ubiquitously expressed nucleolar protein that shuttles between the nucleus and cytoplasm. It is implicated in multiple functions, including ribosomal protein assembly and transport, control of centrosome duplication, and regulation of the tumor suppressor ARF (600160). NPM1 mutations that relocalize NPM1 from the nucleus into the cytoplasm are associated with development of acute myeloid leukemia (AML; 601626) (Garzon et al., 2008).

CLONING

Chan et al. (1989) reported the nucleotide sequence of a cDNA of human nucleophosmin. The cDNA has a coding sequence equivalent to a protein of 294 amino acids. When protein levels were compared with Western blot immunoassays, Novikoff hepatoma showed 20 times more nucleophosmin than normal, and hypertrophic rat liver showed about 5 times more nucleophosmin than unstimulated normal liver. Dalenc et al. (2002) developed a HeLa cell line that overexpressed FGF2 (134920) and showed radioresistance following exposure to ionizing radiation. By differential display, they determined that the radioresistant cells upregulated expression of an NPM1 splice variant. This variant, which Dalenc et al. (2002) designated NPM2, encodes a deduced 259-amino acid protein that differs from the original isolate only at the C terminus. Western blot analysis of HeLa cells detected both NPM isoforms, which migrated with apparent molecular masses of 38 and 34 kD. The amount of the shorter isoform increased following FGF2 overexpression.

GENE FUNCTION

Chan et al. (1989) found that nucleophosmin is a nucleolar phosphoprotein that is more abundant in tumor cells than in normal resting cells. Stimulation of the growth of normal cells, e.g., mitogen activation of B lymphocytes, was accompanied by an increase in nucleophosmin protein level. They stated that nucleophosmin is likely involved in the assembly of ribosomal proteins into ribosomes. Electron microscopic study indicated that nucleophosmin is concentrated in the granular region of the nucleolus, where ribosome assembly occurs. Okuda et al. (2000) identified nucleophosmin as a substrate of CDK2 (116953)/cyclin E (123837) in centrosome duplication. NPM1 associated with unduplicated centrosomes, and dissociated from centrosomes by CDK2/cyclin E-mediated phosphorylation. An anti-NPM1 antibody, which blocked this phosphorylation, suppressed the initiation of centrosome duplication in vivo. Moreover, expression of a nonphosphorylatable mutant NPM1 in cells effectively blocked centrosome duplication. Okuda et al. (2000) concluded that NPM1 is a target of CDK2/cyclin E in the initiation of centrosome duplication. By immunohistochemistry using antibodies that did not differentiate between NPM1 isoforms, Dalenc et al. (2002) found nuclear staining for NPM1 in control HeLa cells and cytoplasmic staining following transfection with FGF2. They concluded that overexpression of FGF2 caused the redistribution of both NPM1 isoforms. By transfection of the C-terminally truncated NPM1 variant (NPM2) into radiosensitive HeLa cells, Dalenc et al. (2002) showed that the radioresistance associated with FGF2 overexpression was mediated by increased expression of this NPM1 isoform. - NPM1/ALK Fusion Protein Zhang et al. (2007) stated that ALK (105590) tyrosine kinase expression is normally confined to neural cells, but chromosomal translocations involving ALK and various partners, most frequently NPM1, result in ectopic expression of ALK in a s ... More on the omim web site

Subscribe to this protein entry history

Feb. 10, 2018: Protein entry updated
Automatic update: Entry updated from uniprot information.

Feb. 2, 2018: Protein entry updated
Automatic update: Uniprot description updated

Dec. 19, 2017: Protein entry updated
Automatic update: Uniprot description updated

Nov. 23, 2017: Protein entry updated
Automatic update: Uniprot description updated

March 16, 2016: Protein entry updated
Automatic update: OMIM entry 164040 was added.

Jan. 24, 2016: Protein entry updated
Automatic update: model status changed